Correction: Persistent symptoms and risk factors predicting prolonged time to symptom-free after SARS-CoV-2 infection: an analysis of the baseline examination of the German COVIDOM/NAPKON-POP cohort - Summary - MDSpire

Correction: Ongoing Symptoms and Predictive Risk Factors for Extended Duration to Symptom Resolution Following SARS-CoV-2 Infection: Insights from the Baseline Assessment of the German COVIDOM/NAPKON-POP Cohort

  • By

  • Yanyan Shi

  • Ralf Strobl

  • Christian Apfelbacher

  • Thomas Bahmer

  • Ramsia Geisler

  • Peter Heuschmann

  • Anna Schäfer

  • Hanno Hoven

  • Thomas Keil

  • Michael Krawczak

  • Lilian Krist

  • Christina Lemhöfer

  • Wolfgang Lieb

  • Bettina Lorenz-Depiereux

  • Rafael Mikolajczyk

  • Felipe A. Montellano

  • Jens Peter Reese

  • Stefan Schreiber

  • Nicole Skoetz

  • Stefan Störk

  • Jörg Janne Vehreschild

  • Martin Witzenrath

  • Eva Grill

  • July 27, 2026

Share

Original Source(s)

Correction: Persistent symptoms and risk factors predicting prolonged time to symptom-free after SARS-CoV-2 infection: an analysis of the baseline examination of the German COVIDOM/NAPKON-POP cohort

  • by Yanyan Shi, Ralf Strobl, Christian Apfelbacher, Thomas Bahmer, Ramsia Geisler, Peter Heuschmann, Anna Schäfer, Hanno Hoven, Thomas Keil, Michael Krawczak, Lilian Krist, Christina Lemhöfer, Wolfgang Lieb, Bettina Lorenz-Depiereux, Rafael Mikolajczyk, Felipe A. Montellano, Jens Peter Reese, Stefan Schreiber, Nicole Skoetz, Stefan Störk, Jörg Janne Vehreschild, Martin Witzenrath, Eva Grill

  • July 27, 2026

Related Content

Association between perfluoroalkyl and polyfluoroalkyl substances and response to the COVID-19 vaccine in a paediatric prospective observational cohort in Arizona

HHS Secretary Kennedy Signs COVID-19 Emergency Use Authorization Declaration Terminations

Why the Test-Negative Design Is Used for Routine Vaccine Monitoring